These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Management of Hyperkalemia: An Update for the Internist. Kovesdy CP Am J Med; 2015 Dec; 128(12):1281-7. PubMed ID: 26093176 [TBL] [Abstract][Full Text] [Related]
4. Potassium Binders for Hyperkalemia in Chronic Kidney Disease-Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis. Palmer BF Mayo Clin Proc; 2020 Feb; 95(2):339-354. PubMed ID: 31668450 [TBL] [Abstract][Full Text] [Related]
5. Review of Hyperkalemia in End Stage Renal Disease. Akbar SR; Ahmed US; Iqbal HI W V Med J; 2016; 112(6):34-8. PubMed ID: 29368827 [TBL] [Abstract][Full Text] [Related]
8. Dyskalemia in Chronic Kidney Disease: How Concerned Should We Be? Tandukar S; Fried LF Nephron; 2018; 140(1):58-62. PubMed ID: 29972830 [TBL] [Abstract][Full Text] [Related]
9. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors. Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174 [TBL] [Abstract][Full Text] [Related]
10. [Effect of hyperkalemia and RAASi nonadherence on patients affected by heart failure or chronic kidney disease]. Degli Esposti L; Perrone V; Giacomini E; Sangiorgi D; Alessandrini D; Santoro A G Ital Nefrol; 2019 Sep; 36(5):. PubMed ID: 31580544 [TBL] [Abstract][Full Text] [Related]
11. Managing Hyperkalemia: Another Benefit of Exercise in People With Chronic Kidney Disease? St-Jules DE; Marinaro M; Goldfarb DS; Byham-Gray LD; Wilund KR J Ren Nutr; 2020 Sep; 30(5):380-383. PubMed ID: 31767517 [TBL] [Abstract][Full Text] [Related]
12. Perioperative hyperkalemia in hemodialysis patients undergoing parathyroidectomy for renal hyperparathyroidism. Yang G; Wang J; Sun J; Zha X; Wang N; Xing C Intern Emerg Med; 2019 Oct; 14(7):1065-1071. PubMed ID: 30648222 [TBL] [Abstract][Full Text] [Related]
13. The effects of angiotensin converting enzyme inhibitors on potassium homeostasis in dialysis patients with and without residual renal function. Garthwaite E; Bhandari S Artif Organs; 2009 Aug; 33(8):641-7. PubMed ID: 19624582 [TBL] [Abstract][Full Text] [Related]
14. Does dietary potassium intake associate with hyperkalemia in patients with chronic kidney disease? Ramos CI; González-Ortiz A; Espinosa-Cuevas A; Avesani CM; Carrero JJ; Cuppari L Nephrol Dial Transplant; 2021 Nov; 36(11):2049-2057. PubMed ID: 33247727 [TBL] [Abstract][Full Text] [Related]
15. Hemodialysis treatment in patients with severe electrolyte disorders: Management of hyperkalemia and hyponatremia. Pirklbauer M Hemodial Int; 2020 Jul; 24(3):282-289. PubMed ID: 32436307 [TBL] [Abstract][Full Text] [Related]